Sleuth closes the data gap by monitoring Chinese-language sources, translating and validating data, and mapping it alongside the global pipeline.
Public source
Publisher name
Public post
What's the most consistent data gap we hear from Pharma BD, S&E and CI teams? China. That's a problem when Chinese sponsors account for half of all ADC, bispecific and C…
Company
Sleuth
Sleuth helps strategic biopharma teams get to conviction faster, turning complex questions into clear answers - in hours
- Industry
- Software Development
- Location
- San Francisco, US
- Company size
- 11–50 employees
About Sleuth
Sleuth replaces patchworks of database subscriptions, consulting engagements, and internal spreadsheets - whether your team runs the analysis or ours does.
See moreLatest activity
Latest activity from Sleuth
9 signals
Research & Knowledge
Sleuth published a report showing that Novartis is the single player with the infrastructure and know-how to operate a radiopharma franchise at global, franchise scale, including 600+ RLT clinical trial sites globally.
Research & Knowledge
Sleuth published a report showing that Novartis has ~1.5K+ therapy centers specialized in administration and treatment, with about half outside the US.
Research & Knowledge
Sleuth published a report showing that Novartis has gone all-in since 2017, with a commitment of over $12B in disclosed potential consideration across 13+ deals, including takeouts of AAA ($3.9B, brought Lutathera), Endocyte ($2.1B, brought Pluvicto), and Mariana Oncology ($1.75B), with Lutathera and Pluvicto generating $1.8B in sales through H1 2026.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Zymewire
Zymewire published a report looking at the companies behind every oral small molecule in Phase 1 or Phase 2 across North America and Europe, and what they have raised in the past two years.
Research & Knowledge
MDClone
MDClone researchers identified the full ILD patient cohort and linked it to long-term outcomes from Israel's national population registry using the MDClone ADAMS Platform.
Research & Knowledge
Solix Technologies, Inc.
Solix Technologies, Inc. VP Life Sciences Raju Pusapati explores how reusable workflows can help organizations get more value from a shared R&D data foundation in the article In Built Once, Used Many Times.
Research & Knowledge
Clutch Holdings
Clutch Holdings reported that a team screened roughly thirty thousand compounds against protein structures predicted by AlphaFold found two existing drugs, pimecrolimus and ledipasvir, active against the parasite in the lab.
Research & Knowledge
Garner Health